title: Reply to: "Experimental aspects of copy number variant assays at CCL3L1".
authors.forename: Weijing
authors.initials: W
authors.lastname: He
authors.forename: Hemant
authors.initials: H
authors.lastname: Kulkarni
authors.forename: John
authors.initials: J
authors.lastname: Castiblanco
authors.forename: Chisato
authors.initials: C
authors.lastname: Shimizu
authors.forename: Una
authors.initials: U
authors.lastname: Aluyen
authors.forename: Robert
authors.initials: R
authors.lastname: Maldonado
authors.forename: Andrew
authors.initials: A
authors.lastname: Carrillo
authors.forename: Madeline
authors.initials: M
authors.lastname: Griffin
authors.forename: Amanda
authors.initials: A
authors.lastname: Lipsitt
authors.forename: Lisa
authors.initials: L
authors.lastname: Beachy
authors.forename: Ludmila
authors.initials: L
authors.lastname: Shostakovich-Koretskaya
authors.forename: Andrea
authors.initials: A
authors.lastname: Mangano
authors.forename: Luisa
authors.initials: L
authors.lastname: Sen
authors.forename: Robert J B
authors.initials: RJ
authors.lastname: Nibbs
authors.forename: Caroline T
authors.initials: CT
authors.lastname: Tiemessen
authors.forename: Hector
authors.initials: H
authors.lastname: Bolivar
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Bamshad
authors.forename: Robert A
authors.initials: RA
authors.lastname: Clark
authors.forename: Jane C
authors.initials: JC
authors.lastname: Burns
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Dolan
authors.forename: Sunil K
authors.initials: SK
authors.lastname: Ahuja
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics; D000465:Algorithms; D023241:Antiretroviral Therapy, Highly Active; D001681:Biological Assay; D016022:Case-Control Studies; D019742:Chemokines, CC / Q000032:analysis* / Q000235:genetics; D002886:Chromosomes, Human, Pair 17; D002893:Chromosomes, Human, Pair 3; D016000:Cluster Analysis; D015331:Cohort Studies; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D015342:DNA Probes / Q000737:chemistry; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics; D018450:Disease Progression; D005006:Ethnicity / Q000235:genetics; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D008024:Ligands; D016133:Polymerase Chain Reaction / Q000379:methods; D044382:Population Groups / Q000235:genetics; D019713:Receptors, CCR5 / Q000235:genetics; D012015:Reference Standards; D015203:Reproducibility of Results; D020079:Terminal Repeat Sequences / Q000235:genetics; D006113:United Kingdom
chemical_list: C492767:CCL3L1 protein, human; C492768:CCL4L1 protein, human; D019742:Chemokines, CC; D015342:DNA Probes; D008024:Ligands; D019713:Receptors, CCR5; D004247:DNA